[1]
P. SANDEEP and K. ILANGO, “A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR”, Journal of Pharmaceutical Negative Results, pp. 217–225, Nov. 2022.